skip to main content

Chemistry, part 1

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > ceramide > ganglioside > sialotetraosylceramide > alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)-beta-gal-d-(1->3)-beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > ceramide > ganglioside > sialotetraosylceramide > alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)-beta-gal-d-(1->3)-beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > organooxygen compound > sphingolipid > ceramide > ganglioside > sialotetraosylceramide > alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)-beta-gal-d-(1->3)-beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > ceramide > ganglioside > sialotetraosylceramide > alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)-beta-gal-d-(1->3)-beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > organooxygen compound > carboxamide > ceramide > ganglioside > sialotetraosylceramide > alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)-beta-gal-d-(1->3)-beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > ceramide > ganglioside > sialotetraosylceramide > alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)-beta-gal-d-(1->3)-beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > liposaccharide > glycolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialotetraosylceramide > alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)-beta-gal-d-(1->3)-beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialotetraosylceramide > alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)-beta-gal-d-(1->3)-beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialotetraosylceramide > alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)-beta-gal-d-(1->3)-beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialotetraosylceramide > alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)-beta-gal-d-(1->3)-beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > organooxygen compound > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialotetraosylceramide > alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)-beta-gal-d-(1->3)-beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer

Preferred term

alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)-beta-gal-d-(1->3)-beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

Broader concept

Narrower concepts

alt_id

  • CHEBI:21170
  • CHEBI:5229

charge

  • 0

formula

  • C89H147N6O55R

has_part

has_role

is_conjugate_acid_of

mass

  • 2181.130

monoisotopicmass

  • 2179.88903

smiles

  • CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O[C@@]5(C[C@H](O)[C@@H](NC(C)=O)[C@@H](O5)[C@H](O)[C@@H](CO)O[C@@]5(C[C@H](O)[C@@H](NC(C)=O)[C@@H](O5)[C@H](O)[C@H](O)CO)C(O)=O)C(O)=O)[C@H]4O)[C@H]3NC(C)=O)[C@H](O[C@@]3(C[C@H](O)[C@@H](NC(C)=O)[C@@H](O3)[C@H](O)[C@@H](CO)O[C@@]3(C[C@H](O)[C@@H](NC(C)=O)[C@@H](O3)[C@H](O)[C@H](O)CO)C(O)=O)C(O)=O)[C@H]2O)[C@H](O)[C@H]1O)NC([*])=O

subset

  • 3_STAR

synonym EXACT

  • (2S,3R,4E)-2-(acylamino)-3-hydroxyoctadec-4-en-1-yl 5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->8)-5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)-[5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->8)-5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)-beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1->4)]-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranoside

synonym RELATED

  • alpha-Neu5Ac-(2->8)-alpha-Neu5Ac-(2->3)-beta-Gal-(1->3)-beta-GalNAc-(1->4)-[alpha-Neu5Ac-(2->8)-alpha-Neu5Ac-(2->3)]-beta-Gal-(1->4)-beta-Glc-(1<->1')-Cer
  • alpha-Neu5Ac-(2->8)-alpha-Neu5Ac-(2->3)-beta-Galp-(1->3)-beta-GalpNAc-(1->4)-[alpha-Neu5Ac-(2->8)-alpha-Neu5Ac-(2->3)]-beta-Galp-(1->4)-beta-Glcp-(1<->1')-Cer
  • (Gal)2 (GalNAc)1 (Glc)1 (Neu5Ac)4 (Cer)1
  • ganglioside GQ1b
  • GQ1
  • GQ1b
  • Neu5Ac-alpha2->8Neu5Ac-alpha2->3Gal-beta1->3GalNAc-beta1->4(Neu5Ac-alpha2->8Neu5Ac-alpha2->3)Gal-beta1->4Glc-beta1->1'Cer
  • Neu5Acalpha2-8Neu5Acalpha2-3Galbeta1-3GalNAcbeta1-4(Neu5Acalpha2-8Neu5Acalpha2-3)Galbeta1-4Glcbeta1-1'Cer
  • Neu5Acalpha2->8Neu5Acalpha2->3Galbeta1->3GalNAcbeta1->4(Neu5Acalpha2->8Neu5Acalpha2->3)Galbeta1->4Glc-Cer
  • Neu5Ac-alpha2->8Neu5Ac-alpha2->3Gal-beta1->3GalNAc-beta1->4(Neu5Ac-alpha2->8Neu5Ac-alpha2->3)LacCer
  • tetrasialoganglioside GQ1b

In other languages

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:27515

Download this concept:

RDF/XML TURTLE JSON-LD